Advertisement
Australia markets close in 2 hours 3 minutes
  • ALL ORDS

    7,846.40
    -163.00 (-2.04%)
     
  • ASX 200

    7,595.40
    -157.10 (-2.03%)
     
  • AUD/USD

    0.6419
    -0.0026 (-0.40%)
     
  • OIL

    85.87
    +0.46 (+0.54%)
     
  • GOLD

    2,404.70
    +21.70 (+0.91%)
     
  • Bitcoin AUD

    98,035.67
    -3,230.88 (-3.19%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • AUD/EUR

    0.6047
    -0.0012 (-0.21%)
     
  • AUD/NZD

    1.0916
    +0.0008 (+0.07%)
     
  • NZX 50

    11,801.94
    -114.84 (-0.96%)
     
  • NASDAQ

    17,706.83
    -296.65 (-1.65%)
     
  • FTSE

    7,965.53
    -30.05 (-0.38%)
     
  • Dow Jones

    37,735.11
    -248.13 (-0.65%)
     
  • DAX

    18,026.58
    +96.26 (+0.54%)
     
  • Hang Seng

    16,287.71
    -312.75 (-1.88%)
     
  • NIKKEI 225

    38,399.96
    -832.84 (-2.12%)
     

What You Need To Know About Equillium, Inc.'s (NASDAQ:EQ) Investor Composition

The big shareholder groups in Equillium, Inc. (NASDAQ:EQ) have power over the company. Large companies usually have institutions as shareholders, and we usually see insiders owning shares in smaller companies. Warren Buffett said that he likes "a business with enduring competitive advantages that is run by able and owner-oriented people." So it's nice to see some insider ownership, because it may suggest that management is owner-oriented.

Equillium is a smaller company with a market capitalization of US$176m, so it may still be flying under the radar of many institutional investors. Taking a look at our data on the ownership groups (below), it seems that institutional investors have bought into the company. We can zoom in on the different ownership groups, to learn more about Equillium.

See our latest analysis for Equillium

ownership-breakdown
ownership-breakdown

What Does The Institutional Ownership Tell Us About Equillium?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

ADVERTISEMENT

As you can see, institutional investors have a fair amount of stake in Equillium. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Equillium's earnings history below. Of course, the future is what really matters.

earnings-and-revenue-growth
earnings-and-revenue-growth

Equillium is not owned by hedge funds. With a 13% stake, CEO Bruce Steel is the largest shareholder. With 9.9% and 8.0% of the shares outstanding respectively, Victory Capital Management Inc. and Biocon Limited are the second and third largest shareholders.

On further inspection, we found that more than half the company's shares are owned by the top 7 shareholders, suggesting that the interests of the larger shareholders are balanced out to an extent by the smaller ones.

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There are plenty of analysts covering the stock, so it might be worth seeing what they are forecasting, too.

Insider Ownership Of Equillium

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

Our most recent data indicates that insiders own a reasonable proportion of Equillium, Inc.. It has a market capitalization of just US$176m, and insiders have US$42m worth of shares in their own names. This may suggest that the founders still own a lot of shares. You can click here to see if they have been buying or selling.

General Public Ownership

The general public, with a 27% stake in the company, will not easily be ignored. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.

Private Company Ownership

It seems that Private Companies own 6.3%, of the Equillium stock. Private companies may be related parties. Sometimes insiders have an interest in a public company through a holding in a private company, rather than in their own capacity as an individual. While it's hard to draw any broad stroke conclusions, it is worth noting as an area for further research.

Public Company Ownership

We can see that public companies hold 8.0% of the Equillium shares on issue. This may be a strategic interest and the two companies may have related business interests. It could be that they have de-merged. This holding is probably worth investigating further.

Next Steps:

It's always worth thinking about the different groups who own shares in a company. But to understand Equillium better, we need to consider many other factors. Like risks, for instance. Every company has them, and we've spotted 3 warning signs for Equillium (of which 1 is a bit concerning!) you should know about.

If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.